Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal mucosa and immune system, primarily organized as the gut-associated lymphoid tissue (GALT), constitute the body's largest immunological organ and a critical interface with the external environment. This system functions as a selective barrier that permits nutrient absorption while providing a robust defense against pathogens and maintaining tolerance to commensal microbiota and dietary antigens (Mowat & Agace, 2014, Nature Reviews Immunology). It consists of specialized epithelial cells, a protective mucus layer, and a diverse population of immune cells, including intraepithelial lymphocytes and plasma cells secreting IgA (Vancamelbeke & Vermeire, 2017, Therapeutic Advances in Gastroenterology). Dysregulation of the intestinal immune response or a breakdown in mucosal barrier integrity is a hallmark of chronic inflammatory conditions such as Crohn's disease and ulcerative colitis (Okumura & Takeda, 2017, International Immunology). Therapeutic strategies often involve modulating specific molecular pathways within this system, such as blocking tumor necrosis factor (TNF) or inhibiting the migration of lymphocytes to the gut via integrin antagonism (Danese et al., 2015, Gut).
Drugs targeting this system typically act by inhibiting pro-inflammatory cytokines, blocking leukocyte trafficking to the gut, or providing local anti-inflammatory effects to restore mucosal barrier function.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal mucosa and immune system (GALT).